The USPTO’s Christine Foster ist still not happy with the triage/trauma NGAL-patent, as the recent development shows.
Triage/Trauma Patent – prosecutions remarks july 2012
While she (CF) seems to acknowledge that the double patenting may be erroneous – she maintains that position until other problems have been solved. On the other hand she maintains that the “new” claim 1 is not applicable as it is differs from what is allowed in finally rejected claims – and secondly that the new claims were not presented earlier. Also Claim 18 seems (to CF) to be contradictionary to claim 1.
So I guess its back to square 1…
One Response to The recent development in Triage/Trauma NGAL-patent
Leave a Reply Cancel reply
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard


[…] I starten af August 2012 skrev Stengaard et indlæg vedrørende traume patentet’s behandling hos de amerikanske patentmyndigheder USPTO. The recent development in Triage/Trauma NGAL-patent. […]